X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-23 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $370.66 | -5,318 | 298 | -95% | -$1,971,160 | |||||
2024-03-01 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale | $383.48 | -1,605 | 298 | -84% | -$615,485 | ||||||
| D | 2024-02-27 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $386.46 | -843 | 298 | -74% | -$325,786 | |||||
| D | 2024-02-12 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $386.09 | -481 | 298 | -62% | -$185,709 | |||||
| D | 2024-01-26 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $370.15 | -4,318 | 189 | -96% | -$1,598,298 | |||||
| D | 2023-11-16 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $300.00 | -8,819 | 189 | -98% | -$2,645,700 | |||||
| D | 2023-09-18 | NKTR | Curet Myriam | Dir | S - Sale+OE | $0.69 | -4,359 | 27,418 | -14% | -$3,008 | |||||
| D | 2023-04-21 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $299.76 | -9,623 | 327 | -97% | -$2,884,579 | |||||
| D | 2023-03-01 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $228.47 | -1,253 | 1,950 | -39% | -$286,273 | |||||
| D | 2023-02-16 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $240.77 | -1,124 | 327 | -77% | -$270,625 | |||||
| D | 2022-11-01 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $250.06 | -8,000 | 217 | -97% | -$2,000,509 | |||||
| D | 2022-10-21 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $209.78 | -8,000 | 217 | -97% | -$1,678,242 | |||||
2022-09-23 | NKTR | Curet Myriam | Dir | S - Sale | $3.16 | -4,198 | 31,777 | -12% | -$13,266 | ||||||
| D | 2022-07-27 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $225.00 | -9,000 | 217 | -98% | -$2,025,000 | |||||
| D | 2022-04-26 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $252.51 | -6,000 | 217 | -97% | -$1,515,058 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |